พบ "Digital Medicine"ทั้งหมด 205 ผลลัพธ์
เรียงลำดับตาม
เรียงลำดับตาม
ความเกี่ยวข้อง
Scaling up health policies and services in low- and middle-income settings. (2010)
Scaling up health policies and services in low- and middle-income settings.
Kara Hanson1*, Susan Cleary2, Helen Schneider3, Sripen Tantivess4, Lucy Gilson1,5
1Department of Global Health and Development, London School of Hygiene and Tropical Medicine, UK.
2Health Economics Unit, University of Cap
Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand.(2011)
Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand
Naiyana Praditsitthikorn,1,2 Yot Teerawattananon,1,3 Sripen Tantivess,1,3 Supon Limwattananon,3 Arthorn Riewpaiboon,2 Saibua Chichareon,4
Nantakan Ieumwananonthachai5 and Viroj Tangcharoensathien3
Economic Evaluation of Rehabilitation Services for Inpatients with Stroke in Thailand: A Prospective Cohort Study (2012)
Economic Evaluation of Rehabilitation Services for Inpatients with Stroke in Thailand: A Prospective Cohort Study.
Orathai Khiaocharoen, BN, PhD1, , , ,
Supasit Pannarunothai, MD, PhD2,
Wachara Riewpaiboon,MD3,
Lily Ingsrisawang, BSc, PhD4,
Yot Teerawattananon, MD, PhD5
1 Hea
Uptake of HIV, Hepatitis B and Hepatitis C testing among injection drug users in Thailand (2015)
Roongnapa Khampang1,2, Sawitri Assanangkornchai2, Linda B Cottler3.
1Epidemiology Unit, Faculty of Medicine, Prince of Songkhla University,
Hatyai, Thailand, 2Health Intervention and Technology Assessment
Programme, Department of Health, Ministry of Public Health, Nonthaburi,
Thailand, 3College
A store-and-forward telemedicine for retinopathy of prematurity screen: is it cost-effective in Thailand? (2015)
Phanthipha Wongwai a, Pritaporn Kingkaew b, Somkiat Asawaphureekorn a, Tharatip Kolatat c
aDepartment of Ophthalmology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40000, Thailand
bHealth Intervention and Technology Assessment Program (HITAP), Nonthaburi 11000, Thailand
cDepartment of Pa
Foreword: Health Economic Evaluations in Low- and Middle-income Countries: Methodological Issues and Challenges for Priority Setting
CATHERINE PITTa,*
ANNA VASSALLa,
YOT TEERAWATTANANONb,
ULLA K. GRIFFITHSa,
LORNA GUINNESSa,
AMIAN WALKERc,
NICOLA FOSTERd and KARA HANSONa
a Department of Global Health & Development, London School of Hygiene & Tropical Medicine, London, UK
b Health Intervention and Technology Assess
Nationwide survey of nutritional management in an Asian upper-middle income developing country government hospitals: Combination of quantitative survey and focus group discussion (2016)
K. Chittawatanarat a, *, K. Tosanguan b, U. Chaikledkaew b, c, S. Tejavanija d, Y. Teerawattananon b
a Division of Trauma and Critical Care, Department of Surgery, Faculty of Medicine, Maharaj Nakorn Chiang Mai Hospital, Intawarorod Road, Sripume, Chiang Mai University, Chiang Mai 50200, Thailand
Evaluating the Value for Money of Precision Medicine from Early Cycle to Market Access: A Comprehensive Review of Approaches and Challenges
Generic reference cases for economic evaluation (EE) of “cure-based” health technologies may not fit into the new healthcare paradigm of precision medicine (PM). Current EE approaches were challenged by the complex evolving decision space of PM, lack of clinical evidence due to small patient cluster
Scientists unveil extensive child cancer research data
S scientists have released the world’s largest collection of genetic data on childhood cancers in a bid to speed up treatment discoveries.The US Pediatric Cancer Genome Project has mapped the entire genome – all the DNA – of 260 young cancer patients.By finding differences between each youngster’s n
นักวิจัย HITAP นำเสนอผลงาน ในการประชุม “1st Meeting South East Asian Pharmacogenomics Research Network (SEAPharm) Symposium for Genetic and Genome-Guided Personalized Medicine in Asia: Overview and Applications”
เมื่อวันที่ 2 กุมภาพันธ์ 2555 ณ โรงแรมสยามซิตี้ ภญ.วรัญญา รัตนวิภาพงษ์ นักวิจัย HITAP ได้นำเสนอผลการศึกษาการประเมินความคุ้มค่าทางการแพทย์ของการให้บริการตรวจคัดกรองยีน HLA-B*1502 เพื่อหลีกเลี่ยงการเกิดผื่นแพ้ยาชนิดกลุ่มอาการ Stevens – Johnson syndrome (SJS) และ Toxic Epidermal Necrolysis (TEN) จากยา
10 / หน้า